Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXPRE: Dexmedetomidine vs midazolam for sedation and extubation time in mechanically ventilated very preterm neonates
2023-508785-16-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and midazolam (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Time-to-extubation. Planned start Aug 2024; status: authorised.
02
Drugs
dexmedetomidinemidazolam
Beyond the preview
Go deeper on 2023-508785-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508785-16-00.